4-bromo-N-(3-((1-phenethyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)methyl)phenyl)benzamide

ID: ALA3128229

PubChem CID: 76329234

Max Phase: Preclinical

Molecular Formula: C27H23BrN6O

Molecular Weight: 527.43

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccc(Br)cc1

Standard InChI:  InChI=1S/C27H23BrN6O/c28-22-11-9-21(10-12-22)27(35)33-23-8-4-7-20(15-23)16-29-25-24-17-32-34(26(24)31-18-30-25)14-13-19-5-2-1-3-6-19/h1-12,15,17-18H,13-14,16H2,(H,33,35)(H,29,30,31)

Standard InChI Key:  KEFIPKHDSKXZAY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
    6.6888   -2.5547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6877   -3.3743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3957   -3.7832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1054   -3.3738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1026   -2.5511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3939   -2.1459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3955   -4.6004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6877   -5.0088    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6875   -5.8260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9789   -6.2301    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9783   -7.0466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6865   -7.4562    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3937   -6.2283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3991   -7.0471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1796   -7.2950    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6566   -6.6293    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1708   -5.9701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4373   -8.0706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2377   -8.2352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4954   -9.0107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9515   -9.6207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2086  -10.3956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0098  -10.5608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5534   -9.9450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2934   -9.1725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8087   -2.1399    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5180   -2.5458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2241   -2.1345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5210   -3.3630    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.9318   -2.5438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6375   -2.1333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6348   -1.3152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9206   -0.9095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2179   -1.3224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3405   -0.9022    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 14  1  0
 13  9  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
  5 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
 28 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 28  1  0
 32 35  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3128229

   4-bromo-N-[3-[[[1-(2-phenylethyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]methyl]phenyl]benzamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 527.43

Molecular Weight (Monoisotopic): 526.1117

AlogP: 5.70

#Rotatable Bonds: 8

Polar Surface Area: 84.73

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: 2

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 2

CX Acidic pKa: ┄

CX Basic pKa: 3.62

CX LogP: 5.53

CX LogD: 5.53

Aromatic Rings: 5

Heavy Atoms: 35

QED Weighted: 0.27

Np Likeness Score: -1.76

References

1. Sartini S, Coviello V, Bruno A, La Pietra V, Marinelli L, Simorini F, Taliani S, Salerno S, Marini AM, Fioravanti A, Orlandi P, Antonelli A, Da Settimo F, Novellino E, Bocci G, La Motta C..  (2014)  Structure-based optimization of tyrosine kinase inhibitor CLM3. Design, synthesis, functional evaluation, and molecular modeling studies.,  57  (4): [PMID:24447248] [10.1021/jm401358b]

Source

Source(1):

• Scientific Literature